MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Efficacy of LSVT-BIG Treatment Compared to Other Physiotherapy in Patients with Parkinson’s Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials

A. Amin, M. Helal, A. Alsokery, H. Sabet, A. Ibrahim, A. Suleiman, I. Yakout, A. Abunamoos, M. Elsayed (Cairo, Egypt)

Meeting: 2025 International Congress

Keywords: Parkinson’s, Timed Up and Go test

Category: Parkinson’s Disease: Pharmacology and Medical Management

Objective: We aim is to assess the efficacy of Lee Silverman Voice Treatment-BIG therapy (LSVT-BIG) compared to other physiotherapy in patients with Parkinson’s Disease (PwP).

Background: PD is a chronic neurodegenerative disease characterized by motor and non-motor symptoms. LSVT-BIG is a new approach that aims to increase movement amplitudes and improve motor symptoms in PwP.

Method: We conducted a comprehensive search across four electronic databases and included RCTs that compare LSVT with other physiotherapy in PwP. A uniform Google sheet was used for data extraction and quality assessments.

Results: We included eight RCTs with a total of 232 patients. LSVT-BIG could improve motor symptoms assessed by UPDRS score; however, this improvement was statistically insignificant compared to the control group (MD = -2.54, 95% CI [-5.22 – 0.14], P-value = 0.06). In subgroup analysis according to follow-up time, it still insignificant at 1 and 4 months. Patients in the LSVT group had significantly better 10-minute walk test improvement (MD = -0.54, 95% CI [-1.04 – -0.04], P-value = 0.04) compared to the control group, but there was no significant difference between the two groups as regards TUG, (MD = -0.40, 95% CI [-1.49 – 0.68], P-value = 0.47), PDQ-39 (MD = 0.68, 95% CI [-2.01 – 3.37], P-value = 0.62), and BDI (MD = -2.04, 95% CI [-4.50 – 0.43], P-value = 0.11).

Conclusion: LSVT-BIG had a beneficial effect in improving motor function and quality of life in PwP, but we could not prove its superiority to other physiotherapy. More RCTs with larger sample sizes are still needed.

Change from baseline in UPDRS score

Change from baseline in UPDRS score

Change from baseline 10-m walk test and TUG

Change from baseline 10-m walk test and TUG

Change from baseline as regards PDQ-39

Change from baseline as regards PDQ-39

Change from baseline as regards BDI

Change from baseline as regards BDI

To cite this abstract in AMA style:

A. Amin, M. Helal, A. Alsokery, H. Sabet, A. Ibrahim, A. Suleiman, I. Yakout, A. Abunamoos, M. Elsayed. Efficacy of LSVT-BIG Treatment Compared to Other Physiotherapy in Patients with Parkinson’s Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/efficacy-of-lsvt-big-treatment-compared-to-other-physiotherapy-in-patients-with-parkinsons-disease-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/efficacy-of-lsvt-big-treatment-compared-to-other-physiotherapy-in-patients-with-parkinsons-disease-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley